Benzinga’s Volume Movers (MNTA, HAIN, BRLI, PAAS)

Momenta Pharmaceuticals Inc MNTA shares moved up 4.15% to $16.33 at 12:25 pm. The volume of MNTA shares traded was 306% higher than normal. US District Judge Emmet Sullivan had denied the issuance of a preliminary injunction, after Sanofi requested to block the generic version of Lovenox, which is already being sold by the Sandoz unit of Novartis and MNTA. The Hain Celestial Group Inc HAIN shares rose 2.86% to $21.24. The volume of HAIN shares traded was 191% higher than normal. HAIN had reported strong Q4 results. Bio-Reference Laboratories Inc BRLI shares climbed 4.12% to $19.98. The volume of BRLI shares traded was 149% higher than normal. BRLI has reported a strong rise in its FQ3 results. Pan American Silver Corp PAAS shares gained 2.40% to $24.77. The volume of PAAS shares traded was 108% higher than normal. PAAS’ earnings are likely to rise by 90.10% this year. Read more from Benzinga's Company news.